Rob Handfield, professor of operations and supply chain management, says drug production in India is at risk given the the current status of the COVID-19 outbreak.
“I’ve got to believe that the number of cases is going to hurt them,” said Handfield. “You’ve got to start testing people. … When you do find someone who’s sick, you’ve got to get people out of there. It’s going to interfere with operations. I don’t see how it won’t.”
Read more on BarChart.
This post was originally published on Poole Thought Leadership here.